Archive for February 28th, 2011

SNTS receives RTF. SGEN submits brentuximab vedotin BLA

Feb 28, 2011 No Comments by

Santarus, Inc. (NASDAQ:SNTS) and biotech company Pharming Group NV (NYSE Euronext:PHARM) today announced the receipt of a refusal to file letter from the FDA for their RHUCIN BLA. The FDA indicated that the previously conducted studies evaluating RHUCIN for the treatment of acute attacks of Hereditary Angioedema (HAE) did not provide data for a sufficient […]

Daily News Read more